UnitedHealth Group Reports 2025 Results with $2.8B Charge, Forecasts 2026 Revenue Decline & Membership Loss
UNH sits 32% above its 52-week low of $234.6.
Summary
UnitedHealth Group reported full year 2025 results impacted by a $2.8 billion charge and issued a 2026 outlook forecasting a revenue decline and significant membership contraction in its UnitedHealthcare segment.
Key Events · Earnings and Guidance · UNH
-
Full Year 2025 Financial Performance
Consolidated revenues grew 12% year-over-year to $447.6 billion. GAAP earnings per share were $13.23, and adjusted earnings per share were $16.35, both lower than 2024, primarily due to significant one-time charges.
-
Substantial Q4 2025 Charge
The company recorded a $2.8 billion pre-tax charge ($1.6 billion net of taxes) in the fourth quarter of 2025. This charge covered final cyberattack costs, net portfolio divestitures, and broader restructuring activities, including real estate rationalization and workforce reductions.
-
2026 Revenue Outlook Declines
UnitedHealth Group projects 2026 revenues to exceed $439.0 billion, representing a 2% year-over-year decline. This reduction is attributed to 'planned right-sizing across the enterprise'.
-
Significant Membership Contraction Expected
UnitedHealthcare anticipates a substantial decrease in people served for 2026, with membership expected to contract by 2.265 million to 2.815 million. This includes significant reductions in Medicare Advantage and Commercial Risk segments.
Analysis · UNH · Finance
UnitedHealth Group's latest 8-K reveals a challenging 2025, marked by a substantial $2.8 billion pre-tax charge for cyberattack costs, divestitures, and restructuring, which significantly impacted GAAP and adjusted earnings per share. While 2025 revenues grew, the company is projecting a 2% revenue decline for 2026 due to 'planned right-sizing.' More critically, UnitedHealthcare anticipates a significant membership contraction of 2.265 million to 2.815 million people in 2026, particularly in its Medicare Advantage and Commercial Risk segments. This strategic pivot, including a projected revenue decline for Optum Health, indicates a period of operational adjustment and potential headwinds, despite an improved adjusted EPS outlook for 2026. Investors should monitor the execution of these 'right-sizing' initiatives and their impact on long-term growth and market share.
At the time of this filing, UNH was trading at $308.96 on NYSE in the Finance sector, with a market capitalization of approximately $318.5B. The 52-week trading range was $234.60 to $606.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.